FDA Warning Letter — CAF-DAF Scrl
The FDA took a Warning Letter action against CAF-DAF Scrl on Aug 29, 2013 (Brussels, Belgium). The action was issued by CBER and concerns biologics products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- CAF-DAF Scrl
- Date
- Aug 29, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Center
- CBER
- Location
- Brussels (Belgium)